Evidence map›Paper›PMID 29348883›Full record

ArticleOncotarget2017

Spatial habitats from multiparametric MR imaging are associated with signaling pathway activities and survival in glioblastoma.

Katherine Dextraze, Abhijoy Saha, Donnie Kim, Shivali Narang, Michael Lehrer, Anita Rao, Saphal Narang, Dinesh Rao, Salmaan Ahmed, Venkatesh Madhugiri and 5 more

2 registry-linked trialsOpen access · diamondAbstract read
In one paragraph

Article in Oncotarget, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 35 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
35citing papers in PubMed, 2 pooled it
1.1field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06002711 recruitingnot on this mapstarted 2023, after this paper: background citation

Multi-Dimensional MRI Spatial Heterogeneity Analysis for Predicting Key Genes and Prognosis of High-Grade Gliomas: A Multi-Center Study

TypeobservationalSponsorRenJi HospitalRan2023 to 2027Enrolled500ConditionsHigh-grade GliomaArmsMR scanning, Clinical data collection
NCT06144762 narecruitingnot on this mapstarted 2023, after this paper: background citation

Precision Imaging for Early Detection and Targeted Treatment Monitoring in Pancreatic Cancer

TypeinterventionalSponsorInstitut du Cancer de Montpellier - Val d'AurelleRan2023 to 2029Enrolled150ConditionsPancreas CancerArmsBiological/Vaccine: Blood sample and tissue sample
3 · Its place in the literature

Who cites it

35 citing papers in PubMed, 2 syntheses or guidelines pooled it, 41 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 7 institutions in 2 countries.

Katherine Dextraze *Department of Medical Physics, The University of Texas Graduate School of Biomedical Sciences, Houston, TX, USA.
Abhijoy Saha *Department of Statistics, The Ohio State University, Columbus, OH, USA.
Donnie KimBioinformatics and Computational Biology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Shivali NarangBioinformatics and Computational Biology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Michael LehrerBioinformatics and Computational Biology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Anita RaoTexas Academy of Math and Science, Denton, TX, USA.
Saphal NarangDebakey High School for Health Professions, Houston, TX, USA.
Dinesh RaoRadiology, University of Florida, College of Medicine, Jacksonville, FL, USA.
Salmaan AhmedDiagnostic Radiology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Venkatesh MadhugiriNeurosurgery, Tata Memorial Hospital, Mumbai, India.
Clifton David FullerRadiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Michelle M KimRadiation Oncology, The University of Michigan, Ann Arbor, MI, USA.
Sunil KrishnanRadiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Ganesh RaoNeurosurgery, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Arvind RaoBioinformatics and Computational Biology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
The University of Texas MD Anderson Cancer Center · USColumbia University · USFlorida College · USMichael E. DeBakey VA Medical Center · USTata Memorial Hospital · INThe Ohio State University · USUniversity of Michigan–Ann Arbor · US

Funding

Modeling Apoptotic Suppression in a Mouse Model of Brain TumorsK08NS070928 · NINDS · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI RAO, GANESH · 2011 to 2015
$913k
NINDS NIH HHS K08 NS070928
6 · The paper itself

Abstract

Glioblastoma (GBM) show significant inter- and intra-tumoral heterogeneity, impacting response to treatment and overall survival time of 12-15 months. To study glioblastoma phenotypic heterogeneity, multi-parametric magnetic resonance images (MRI) of 85 glioblastoma patients from The Cancer Genome Atlas were analyzed to characterize tumor-derived spatial habitats for their relationship with outcome (overall survival) and to identify their molecular correlates (i.e., determine associated tumor signaling pathways correlated with imaging-derived habitat measurements). Tumor sub-regions based on four sequences (fluid attenuated inversion recovery, T1-weighted, post-contrast T1-weighted, and T2-weighted) were defined by automated segmentation. From relative intensity of pixels in the 3-dimensional tumor region, "imaging habitats" were identified and analyzed for their association to clinical and genetic data using survival modeling and Dirichlet regression, respectively. Sixteen distinct tumor sub-regions ("spatial imaging habitats") were derived, and those associated with overall survival (denoted "relevant" habitats) in glioblastoma patients were identified. Dirichlet regression implicated each relevant habitat with unique pathway alterations. Relevant habitats also had some pathways and cellular processes in common, including phosphorylation of STAT-1 and natural killer cell activity, consistent with cancer hallmarks. This work revealed clinical relevance of MRI-derived spatial habitats and their relationship with oncogenic molecular mechanisms in patients with GBM. Characterizing the associations between imaging-derived phenotypic measurements with the genomic and molecular characteristics of tumors can enable insights into tumor biology, further enabling the practice of personalized cancer treatment. The analytical framework and workflow demonstrated in this study are inherently scalable to multiple MR sequences.

Indexed as

Dirichlet regressionglioblastomaimage-derived spatial habitatimaging-genomics analysissignaling pathway activity

Identifiers

PMID29348883
PMCPMC5762568
OpenAlexW2774194142

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.